On the practice of rapid blood pressure reduction with oral medications. A scientific view
https://doi.org/10.15829/1728-8800-2025-4197
EDN: VTIHDC
Abstract
Contrary to modern guidelines for the treatment of hypertension, oral and sublingual antihypertensive medications are often used in real-world practice to quickly reduce asymptomatic or low-symptom elevated blood pressure (BP). Doctors and patients explain this by the need to "stop an uncomplicated hypertensive crisis" for preventing cardiovascular events. Clinical trial data indicate that such an approach, both the prescription of short-acting drugs at an outpatient or inpatient levels, and recommendations for self-treatment of hypertension, not only does not benefit the patient, but is also likely to be associated with an increased risk of cardiovascular events. Shifting the focus of hypertension treatment from improving the long-term prognosis to immediate BP reduction may increase short-term variability of BP, which is a possible mechanism for the development of complications when using fast-acting oral antihypertensives. The article substantiates the unacceptability of emergency BP reduction with oral and sublingual antihypertensive drugs. It describes rational actions of a physician in case of detection of asymptomatic or low-symptom BP increase in a patient and presents possible approaches to home BP self-monitoring in accordance with modern clinical guidelines. It also describes the management of true hypertensive crises depending on the characteristics of hypertension-mediated organ damage.
About the Authors
A. D. ErlikhRussian Federation
Krasnogorsk, Moscow
A. V. Rodionov
Russian Federation
Moscow
I. S. Yavelov
Russian Federation
Moscow
D. Yu. Shchekochikhin
Russian Federation
Krasnogorsk, Moscow
V. V. Kashtalap
Russian Federation
Kemerovo
S. Yu. Martsevich
Russian Federation
Moscow
S. T. Matskeplishvili
Russian Federation
Moscow
References
1. Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285-92. doi:10.1161/HYPERTENSIONAHA.119.14240.
2. Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2:775-81. doi:10.1001/jamacardio.2017.1421.
3. Prabhakaran D, Anand S, Watkins D, et al. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities. 3rd ed. Lancet. 2018;391:1224-36. doi:10.1016/S0140-6736(17)32471-6.
4. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874-2071. doi:10.1097/HJH.0000000000003480.
5. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organization (ESO). Eur Heart J. 2024;45(38):3912-4018. doi:10.1093/eurheartj/ehae178.
6. Kallioinen N, Hill A, Horswill MS, et al. Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421-41. doi:10.1097/HJH.0000000000001197.
7. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211.
8. Janeway TC. A clinical study of hypertensive cardiovascular disease. JAMA Intern Med. 1913;755-98. doi:10.1001/archinte.1913.00070060147012.
9. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202.
10. Van der Born B-J, Lip GYH, Brguljan-Hitij J, et al. ESC Council on Hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5;1:37-46. doi:10.1093/ehjcvp/pvy032.
11. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.
12. Rossi GP, Rossitto G, Maifredini C, et al. Management of hypertensive emergencies: a practical approach. Blood Press. 2021; 30(4):208-19. doi:10.1080/08037051.2021.1917983.
13. Dela U, Rido M, Monica T.Sublingual versus oral captopril for blood pressure reduction in hypertension urgency: a systematic review and meta-analysis. J Hypertens. 2021;39:e13. doi:10.1097/01.hjh.0000752556.41180.65.
14. Grassi D, O’Flaherty M, Pellizzari M, et al. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008;10:662-7. doi:10.1111/j.1751-7176.2008.00001.x.
15. Levy PD, Mahn JJ, Miller J, et al. Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort. Am J Emerg Med. 2015;33:1219-24. doi:10.1016/j.ajem.2015.05.036.
16. Sricharoen P, Poungnil A, Yuksen C.Immediate Prescription of Oral Antihypertensive Agents in Hypertensive Urgency Patients and the Risk of Revisits with Elevated Blood Pressure. Open Access Emerg Med. 2020;12:333-40. doi:10.2147/OAEM.S275799.
17. Park SK, Lee DY, Kim WJ, et al. Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial. J Hypertens. 2017;35(7):1474-80. doi:10.1097/HJH.0000000000001340.
18. Hsu C-Y, Huang L-Y, Saver JL, et al. Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study. Hypertens Res. 2019;42(11):1794-800. doi:10.1038/s41440-019-0300-0.
19. Mohandas R, Chamarthi G, Bozorgmehri S, et al. PRN Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity Matched Cohort Study. Hypertension. 2021;78(2):516-24. doi:10.1161/HYPERTENSIONAHA.121.17279.
20. Rastogi R, Sheehan MM, Hu B, et al. Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. JAMA Intern Med. 2021;181(3):345-52. doi:10.1001/jamainternmed.2020.7501.
21. San Jose-Saras D, Vicente-Guijarro J, Sousa P, et al. Inappropriate hospital admission as a risk factor for the subsequent development of adverse events: a cross-sectional study. BMC Med. 2023;21(1):312-24. doi:10.1186/s12916-023-03024-0.
22. Ostroumova OD, Borisova EV, Ostroumova TM, et al. 24-Hour Arterial Pressure Variability: Prognostic Significance, Methods of Evaluation, Effect of Antihypertensive Therapy. Kardiologiia. 2017;57(12):62-72. (In Russ.) doi:10.18087/cardio.2017.12.10068.
23. Parati G, Stergiou GS, Dolan E, et al. Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich). 2018;20(7):1133-7. doi:10.1111/jch.13304.
24. Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and metaanalysis. BMJ. 2016;354:i4098. doi:10.1136/bmj.i4098.
25. Rodionov AV. Uncomplicated hypertensive crisis or high blood pressure variability? Therapeutic Archive. 2017;89(3):108-11. (In Russ.) doi:10.17116/terarkh2017893108-111.
26. Bress AP, Anderson TS, Flack JM, et al. on behalf of the American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association. Hypertension. 2024;81:e01-e13. doi:10.1161/HYP.0000000000000238.
27. Osipova VV, Tabeeva GR, Trinitatskiy YuV, et al. Primary headaches: clinical presentation, diagnostics, therapy. Information letter (for neurologists, therapists, general practitioners). Rostovon-Don: "Antey", 2011. (In Russ.) ISBN: 978-5-91365-157-0.
28. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. doi:10.1093/eurheartj/ehab484.
Supplementary files
What is already known about the subject?
- In real-world practice, oral/sublingual medications are often used to quickly reduce asymptomatic/low-symptom elevated blood pressure (BP), although such management of uncomplicated hypertensive crises is not supported by modern guidelines.
What might this study add?
- Based on research data, criticism of such rapid "treatment" of hypertension is substantiated, which does not bring benefits, but can increase the risk of cardiovascular events.
- Rational actions of a physician when detecting asymptomatic/low-symptom BP increase, possible approaches to home self-monitoring of BP, as well as management of true hypertensive crises are described.
Review
For citations:
Erlikh A.D., Rodionov A.V., Yavelov I.S., Shchekochikhin D.Yu., Kashtalap V.V., Martsevich S.Yu., Matskeplishvili S.T. On the practice of rapid blood pressure reduction with oral medications. A scientific view. Cardiovascular Therapy and Prevention. 2025;24(1):4197. (In Russ.) https://doi.org/10.15829/1728-8800-2025-4197. EDN: VTIHDC